nach oben

Current Psychiatry Reports

Erschienen in:

01.12.2014 | Sleep Disorders (P Gehrman, Section Editor)

Sleep-Disordered Breathing and Psychiatric Disorders

verfasst von: Haider A. Naqvi, David Wang, Nicholas Glozier, Ronald R. Grunstein

Erschienen in: Current Psychiatry Reports | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Sleep-disordered breathing, the commonest form of which is obstructive sleep apnoea (OSA) is increasingly recognised as a treatable cause of morbidity. It shares many risk factors with psychiatric disorders including behaviours such as smoking and physical comorbidity. Many symptoms of the two overlap, leaving OSA often undetected and undertreated. In the few studies that assess the two, OSA is commonly comorbid with depression (17–45 %) and schizophrenia (up to 55 %) and possibly bipolar. There is some limited evidence that treating OSA can ameliorate psychiatric symptoms. Some psychotropics, such as narcotics, cause sleep-disordered breathing (SDB), whilst weight-inducing neuroleptics may exacerbate it. An extreme form of SDB, sudden infant death syndrome (SIDS), is a risk in mothers with substance abuse. Being aware of these common comorbidities may help improve psychiatric patient’s treatment and quality of life.

1.•

Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736–47. doi:10.1016/s0140-6736(13)60734-5. Recently published comprehensive review describing clinical features, pathophysiology, risk factors, consequences and management of OSA.CrossRefPubMedCentralPubMed

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5. doi:10.1056/nejm199304293281704.CrossRefPubMed

Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis. 2009;51(4):285–93. doi:10.1016/j.pcad.2008.08.001.CrossRefPubMed

Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–53. doi:10.1016/s0140-6736(05)71141-7.CrossRefPubMed

Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004;59(7):618–22.CrossRefPubMedCentralPubMed

Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27(3):453–8.PubMed

Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med. 2001;164(11):2031–5. doi:10.1164/ajrccm.164.11.2102028.CrossRefPubMed

Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys. Int J Methods Psychiatr Res. 2003;12(1):3–21.CrossRefPubMed

Harris M, Glozier N, Ratnavadivel R, Grunstein RR. Obstructive sleep apnea and depression. Sleep Med Rev. 2009;13(6):437–44. doi:10.1016/j.smrv.2009.04.001.CrossRefPubMed

10.

Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005;90(8):4510–5. doi:10.1210/jc.2005-0035.CrossRefPubMed

11.

Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry. 2003;64(10):1195–200. quiz, 274–6.CrossRefPubMed

12.

Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005;28(11):1405–11.PubMed

13.

Wheaton AG, Perry GS, Chapman DP, Croft JB. Sleep disordered breathing and depression among U.S. adults: National Health And Nutrition Examination Survey, 2005–2008. Sleep. 2012;35(4):461–7.PubMedCentralPubMed

14.

McCall WV, Harding D, O’Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med. 2006;2(4):424–6.PubMed

15.

Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005;28(3):309–14.PubMed

16.•

Douglas N, Young A, Roebuck T, Ho S, Miller BR, Kee K, et al. Prevalence of depression in patients referred with snoring and obstructive sleep apnoea. Intern Med J. 2013;43(6):630–4. doi:10.1111/imj.12108. In this study depression was found in approximately 50% of patients referred with snoring or OSA, which is 2.5 times higher than that reported for general population.CrossRefPubMed

17.

Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med. 2006;166(16):1709–15. doi:10.1001/archinte.166.16.1709.CrossRefPubMed

18.••

Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC. Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med. 2013;9(5):417–23. doi:10.5664/jcsm.2652. This is a population based study showing that OSA was associated with a 2.18 times increased risk of subsequent depression within a year, compared to controls. The risk was particularly evident among women.PubMedCentralPubMed

19.

Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep. 1996;19(7):531–8.PubMed

20.

Reynolds 3rd CF, Kupfer DJ, McEachran AB, Taska LS, Sewitch DE, Coble PA. Depressive psychopathology in male sleep apneics. J Clin Psychiatry. 1984;45(7):287–90.PubMed

21.

Kales A, Caldwell AB, Cadieux RJ, Vela-Bueno A, Ruch LG, Mayes SD. Severe obstructive sleep apnea—II: associated psychopathology and psychosocial consequences. J Chron Dis. 1985;38(5):427–34.CrossRefPubMed

22.

Sforza E, de Saint HZ, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3(2):139–45.CrossRefPubMed

23.

Deldin PJ, Phillips LK, Thomas RJ. A preliminary study of sleep-disordered breathing in major depressive disorder. Sleep Med. 2006;7(2):131–9. doi:10.1016/j.sleep.2005.06.005.CrossRefPubMed

24.

Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. The Cochrane database of systematic reviews. 2006 (3):Cd001106. doi:10.1002/14651858.CD001106.pub3.

25.

Haensel A, Norman D, Natarajan L, Bardwell WA, Ancoli-Israel S, Dimsdale JE. Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath. 2007;11(4):239–44. doi:10.1007/s11325-007-0115-0.CrossRefPubMed

26.

Bardwell WA, Norman D, Ancoli-Israel S, Loredo JS, Lowery A, Lim W, et al. Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med. 2007;5(1):21–38. doi:10.1080/15402000709336724.CrossRefPubMed

27.

Lee IS, Bardwell W, Ancoli-Israel S, Loredo JS, Dimsdale JE. Effect of three weeks of continuous positive airway pressure treatment on mood in patients with obstructive sleep apnoea: a randomized placebo-controlled study. Sleep Med. 2012;13(2):161–6. doi:10.1016/j.sleep.2011.09.005.CrossRefPubMedCentralPubMed

28.••

Gagnadoux F, Le Vaillant M, Goupil F, Pigeanne T, Chollet S, Masson P et al. Depressive symptoms before and after long-term CPAP Therapy in patients with sleep apnea. Chest. 2014. This prospective study of OSA patients with depression shows improvement in depressive scores in majority of patients following an average of 529 days of CPAP therapy. The persistence of depression was independently associated with persistence of EDS, comorbid cardiovascular disease and female sex

29.

Marshall NS, Neill AM, Campbell AJ, Sheppard DS. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax. 2005;60(5):427–32. doi:10.1136/thx.2004.032078.CrossRefPubMedCentralPubMed

30.

Habukawa M, Uchimura N, Kakuma T, Yamamoto K, Ogi K, Hiejima H, et al. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: contribution of daytime sleepiness to residual depressive symptoms. Sleep Med. 2010;11(6):552–7. doi:10.1016/j.sleep.2010.02.007.CrossRefPubMed

31.

Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187(8):879–87. doi:10.1164/rccm.201212-2223OC.CrossRefPubMed

32.

Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2005;1(4):374–80.PubMed

33.

Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170(6):656–64. doi:10.1164/rccm.200311-1571OC.CrossRefPubMed

34.

Povitz M, Bolo C, Heitman S, Tsai W. Effect of treatment of osbtructive sleep apnea on depresive symptoms: Systemic review and meta-analysis. 2014 (un-published).

35.

Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29(2):147–55. doi:10.1016/j.genhosppsych.2006.11.005.CrossRefPubMed

36.

Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216–26.CrossRefPubMed

37.

Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58(3):175–89. doi:10.1016/j.biopsych.2005.05.001.CrossRefPubMed

38.

Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med. 2005;6(4):341–6. doi:10.1016/j.sleep.2005.02.004.CrossRefPubMed

39.

Akashiba T, Kawahara S, Akahoshi T, Omori C, Saito O, Majima T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest. 2002;122(3):861–5.CrossRefPubMed

40.

Law M, Naughton MT, Ho S, Roebuck T, Dabscheck EJ. Depression may reduce adherence during CPAP titration trial. J Clin Sleep Med. 2014.

41.

Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374–83. doi:10.1016/j.bbi.2007.01.010.CrossRefPubMed

42.

Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151–8. doi:10.1210/jcem.85.3.6484.CrossRefPubMed

43.

Lambert T. Multidimensional approaches to incomplete recovery in psychosis. Therapy-resistant schisophrenia. Basel: Krager; 2010. p. 87–113.

44.

Hoyt BD. Sleep in patients with neurologic and psychiatric disorders. Primary care. 2005;32 (2):535–48, ix. doi:10.1016/j.pop.2005.02.013.

45.

Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull. 2004;30(4):957–67.CrossRefPubMed

46.

Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry J Ment Sci. 2012;200(4):308–16. doi:10.1192/bjp.bp.111.096321.CrossRef

47.

Ferrarelli F, Huber R, Peterson MJ, Massimini M, Murphy M, Riedner BA, et al. Reduced sleep spindle activity in schizophrenia patients. Am J Psychiatry. 2007;164(3):483–92. doi:10.1176/appi.ajp.164.3.483.CrossRefPubMed

48.

Ferrarelli F, Peterson MJ, Sarasso S, Riedner BA, Murphy MJ, Benca RM, et al. Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles. Am J Psychiatry. 2010;167(11):1339–48. doi:10.1176/appi.ajp.2010.09121731.CrossRefPubMedCentralPubMed

49.

Parks J, Svendsen D, Singer P, Foti M. Morbidity and mortality in people with serious mental illness. National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council. 2006

50.

Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE. 2011;6(5):e19590. doi:10.1371/journal.pone.0019590.CrossRefPubMedCentralPubMed

51.

Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425–48. doi:10.1146/annurev-clinpsy-032813-153657.CrossRefPubMed

52.

Bell RC, Farmer S, Ries R, Srebnik D. Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatric services (Washington, DC). 2009;60 (12):1686–9. doi:10.1176/appi.ps.60.12.1686.

53.

Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82–93. doi:10.1016/s0140-6736(08)61622-0.CrossRefPubMed

54.

Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand. 2009;119(1):4–14. doi:10.1111/j.1600-0447.2008.01317.x.CrossRefPubMed

55.••

Kalucy MJ, Grunstein R, Lambert T, Glozier N. Obstructive sleep apnoea and schizophrenia—a research agenda. Sleep Med Rev. 2013;17(5):357–65. doi:10.1016/j.smrv.2012.10.003. This is a comprehensive review that describes the complex association between schizophrenia, obesity, metabolic syndrome and OSA.CrossRefPubMed

56.

Lambert TJ, Newcomer JW. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Aust. 2009;190(4 Suppl):S39–42.PubMed

57.

Winkelman JW. Schizophrenia, obesity, and obstructive sleep apnea. The Journal of clinical psychiatry. 2001;62(1):8–11.CrossRefPubMed

58.

Takahashi KI, Shimizu T, Sugita T, Saito Y, Takahashi Y, Hishikawa Y. Prevalence of sleep-related respiratory disorders in 101 schizophrenic inpatients. Psychiatry Clin Neurosci. 1998;52(2):229–31. doi:10.1111/j.1440-1819.1998.tb01046.x.CrossRefPubMed

59.

Ancoli-Israel S, Martin J, Jones DW, Caligiuri M, Patterson T, Harris MJ, et al. Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry. 1999;45(11):1426–32.CrossRefPubMed

60.

Haque M, Anwar M, Crowe C, Brophy J, Stokes M. Undiagnosed obstructive sleep apnoea in schizophrenia. J Sleep Res. 2008;17:S150.

61.

Rishi MA, Shetty M, Wolff A, Amoateng-Adjepong Y, Manthous CA. Atypical antipsychotic medications are independently associated with severe obstructive sleep apnea. Clin Neuropharmacol. 2010;33(3):109–13. doi:10.1097/WNF.0b013e3181db8040.CrossRefPubMed

62.

Freudenmann RW, Sussmuth SD, Wolf RC, Stiller P, Schonfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry. 2008;41(3):119–21. doi:10.1055/s-2008-1058111.CrossRefPubMed

63.

Lalley PM. D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons. Am J Physiol Regul Integr Comp Physiol. 2009;296(6):R1829–36. doi:10.1152/ajpregu.00057.2009.CrossRefPubMedCentralPubMed

64.

Hennessy RJ, Baldwin PA, Browne DJ, Kinsella A, Waddington JL. Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia. Schizophr Res. 2010;122(1–3):63–71. doi:10.1016/j.schres.2010.05.001.CrossRefPubMedCentralPubMed

65.

Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31(8):1079–85.PubMedCentralPubMed

66.

Wirshing DA, Pierre JM, Wirshing WC. Sleep apnea associated with antipsychotic-induced obesity. J Clin Psychiatry. 2002;63(4):369–70.CrossRefPubMed

67.

Bottlender R, Moller HJ. Negative symptoms due to sleep apnea syndrome in a patient with a delusional disorder. European psychiatry J the Association of European Psychiatrists. 1999;14(6):352.CrossRef

68.

Boufidis S, Kosmidis MH, Bozikas VP, Daskalopoulou-Vlahoyianni E, Pitsavas S, Karavatos A. Treatment outcome of obstructive sleep apnea syndrome in a patient with schizophrenia: case report. Int J Psychiatry Med. 2003;33(3):305–10.CrossRefPubMed

69.

Karanti A, Landen M. Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report. Psychopharmacol Bull. 2007;40(1):113–7.PubMed

70.

Martin PR, Lefebvre AM. Surgical treatment of sleep-apnea-associated psychosis. Can Med Assoc J. 1981;124(8):978–80.PubMedCentralPubMed

71.

Lee S, Chiu HF, Chen CN. Psychosis in sleep apnoea. Aust N Z J Psychiatry. 1989;23(4):571–3.CrossRefPubMed

72.

Manoach DS, Thakkar KN, Stroynowski E, Ely A, McKinley SK, Wamsley E, et al. Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages. J Psychiatr Res. 2010;44(2):112–20. doi:10.1016/j.jpsychires.2009.06.011.CrossRefPubMedCentralPubMed

73.

Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51. doi:10.1001/archgenpsychiatry.2011.12.CrossRefPubMedCentralPubMed

74.

Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165(7):820–9. doi:10.1176/appi.ajp.2008.08010098.CrossRefPubMed

75.

Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatric services (Washington, DC). 2009;60 (2):147–56. doi:10.1176/appi.ps.60.2.147.

76.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10(2):342–8. doi:10.1111/j.1399-5618.2007.00520.x.CrossRefPubMed

77.•

Kelly T, Douglas L, Denmark L, Brasuell G, Lieberman DZ. The high prevalence of obstructive sleep apnea among patients with bipolar disorders. J Affect Disord. 2013;151(1):54–8. doi:10.1016/j.jad.2013.05.047. This is a retrospective study showing higher prevalence of OSA up to 47.5% in patients with bipolar disorder.CrossRefPubMed

78.

Trakada G, Steiropoulos P, Bouros D. Continuous positive airways pressure treatment in a patient with sleep apnea-hypopnea syndrome and coexisting bipolar disorder. Psychopharmacol Bull. 2008;41(12):89–92.PubMed

79.

Berge D, Salgado P, Rodriguez A, Bulbena A. Onset of mania after CPAP in a man with obstructive sleep apnea. Psychosomatics. 2008;49(5):447–9. doi:10.1176/appi.psy.49.5.447.CrossRefPubMed

80.

Aggarwal R, Baweja R, Saunders EF, Singareddy R. CPAP-induced mania in bipolar disorder: a case report. Bipolar Disord. 2013;15(7):803–7. doi:10.1111/bdi.12112.CrossRefPubMedCentralPubMed

81.

Caplehorn JR, Drummer OH. Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med J Aust. 1999;170(3):104–9.PubMed

82.

Drummer OH, Opeskin K, Syrjanen M, Cordner SM. Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. Am J Forensic Med Pathol. 1992;13(4):346–50.CrossRefPubMed

83.

Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev. 2007;11(1):35–46.CrossRefPubMed

84.••

Wang D, Teichtahl H, Drummer OH, Goodman C, Cherry G, Cunnington D, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128:1348–56. This is the first major study reporting significant cantral sleep apnea in chronic opioid users, together with potential ventilatory control mechanisms.CrossRefPubMed

85.••

Walker JM, Farney RJ, Rhondeau SM, Boyle KM, Valentine K, Cloward TV, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007;3(5):455–61. This is a major study reporting central sleep apnea particularly ataxic breathing in a large cohort of chronic opioid users.PubMedCentralPubMed

86.

American Academy of Sleep Medicine. International classification of sleep disorders, second edition: diagnostic and coding manual. Westcherter, IL: American Academy of Sleep Medicine; 2005

87.

Teichtahl H, Wang D, Cunnington D, Quinnell T, Tran H, Kronborg I, et al. Ventilatory response to hypoxia and hypercapnia in stable methadone maintenance treatment patients. Chest. 2005;128:1339–47.CrossRefPubMed

88.

Feldman JL, Del Negro CA. Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci. 2006;7(3):232–42.CrossRefPubMedCentralPubMed

89.

Wang D, Rowsell L, Yee BJ. Positive airway pressure treatment for opioid-related central sleep apnea, where are we now? Sleep Breath. 2014;18:229–31. doi:10.1007/s11325-013-0901-9.CrossRefPubMed

90.

Ward SL, Bautista D, Chan L, Derry M, Lisbin A, Durfee MJ, et al. Sudden infant death syndrome in infants of substance-abusing mothers. J Pediatr. 1990;117(6):876–81.CrossRefPubMed

91.

Ward SL, Schuetz S, Kirshna V, Bean X, Wingert W, Wachsman L, et al. Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers. Am J Dis Child. 1986;140(10):1015–20.PubMed

92.

McCann UD, Sgambati FP, Schwartz AR, Ricaurte GA. Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers. Neurology. 2009;73(23):2011–7. doi:10.1212/WNL.0b013e3181c51a62.CrossRefPubMedCentralPubMed

93.

Li CT, Bai YM, Lee YC, Mao WC, Chen MH, Tu PC et al. High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression. Sleep. 2014;37 (4):803–9, 9A-9B. doi:10.5665/sleep.3594.

94.

Benson K, Zarcone V. Sleep abnormalitis in schizophrenia and other psychotic disorders. Review of Psychiatry, vol 13 Washington: American Psychiatric Press. 1994:p. 677–705. chapter 27.

95.

Alam A, Chengappa KN, Ghinassi F. Screening for obstructive sleep apnea among individuals with severe mental illness at a primary care clinic. Gen Hosp Psychiatry. 2012;34(6):660–4. doi:10.1016/j.genhosppsych.2012.06.015.CrossRefPubMed

96.

Waters F, Hanken K, Rock D. Sleep-disordered breathing in schizophrenia: an audit. Schizophr Res. 2013;143(2–3):393–4. doi:10.1016/j.schres.2012.11.034.CrossRefPubMed

97.

Annamalai A, Palmese LB, Chwastiak LA, Srihari VH, Tek C. High rates of obstructive sleep apnea symptoms among patients with schizophrenia. Psychosomatics. 2014. doi:10.1016/j.psym.2014.02.009

Titel: Sleep-Disordered Breathing and Psychiatric Disorders
verfasst von: Haider A. Naqvi
David Wang
Nicholas Glozier
Ronald R. Grunstein
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 12/2014
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-014-0519-z

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Sleep-Disordered Breathing and Psychiatric Disorders

Abstract

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2014

Distinguishing Bipolar Disorder From Other Psychiatric Disorders in Children

Proceed with Caution: Off-label Ketamine Treatment for Major Depressive Disorder

Professional Social Networking

Nonpharmacologic Treatments for Depression Related to Reproductive Events

Wake-Promoting Pharmacotherapy for Psychiatric Disorders

The Use of Electronic Games in Therapy: a Review with Clinical Implications

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie